Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE

Standard Dose
50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 088587 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE Form and strength SOLUTION;ORAL - 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROXANE Submission history Latest submission status date: 2001-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 088587 (ANDA). Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE Form and strength SOLUTION;ORAL - 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROXANE Submission history Latest submission status date: 2001-10-25 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.